
Sign up to save your podcasts
Or


Are you part of the 70%?
Vitamin D deficiency is a silent crisis affecting both the U.S. and Europe. The lack of this essential nutrient can lead to severe mental health issues, including depression and anxiety, due to its role in serotonin production. Physical health is also at risk, with increased chances of respiratory issues and even cancer. In this eye-opening episode, we delve into the Huberman Lab Podcast, where Dr. Andrew Huberman and his guest Dr. Rhonda Patrick, discuss the alarming rates and severe health consequences of Vitamin D deficiency.
Who are Dr. Andrew Huberman and Dr. Rhonda Patrick?
Dr. Andrew Huberman is a renowned neuroscientist and professor at Stanford University. His guest, Dr. Rhonda Patrick, is an expert in nutritional health. Together, they unpack the science behind Vitamin D, its crucial role in our body, and why you should be concerned about your Vitamin D levels.
Who Needs to Watch This?
If you care about your mental and physical health, this episode is a must-watch. Whether you're in the U.S. or Europe, young or old, the information here is vital for everyone.
What You'll Learn:
Timestamps:
(01:22) Introduction to Vitamin D's Importance
(01:46) Vitamin D and Skin Color
(03:17) Vitamin D Deficiency in the Population
(04:49) Vitamin D and Gene Regulation
(04:59) Vitamin D and Serotonin
(07:15) Importance of Testing Vitamin D Levels
(07:27) Vitamin D Supplementation Dosage
Take Control of Your Health
Don't be part of the statistics. Consult your physician or pharmacy today to get your Vitamin D levels checked. Your health is in your hands.
🎧 Don't forget to leave us a review and share this episode with your network!
🎧 Subscribe for more exclusive content from industry leaders.
🎧 Special thanks to our sponsors. Check out the companies that make this podcast possible!
Send us Fan Mail
Support the show
Join the Podcast Newsletter: Link
Your Next Move: Link
Did you know that the fight against climate change is shaping up to be the biggest business opportunity since the rise of the internet?
Imagine a multi-trillion-dollar market waiting to be tapped! Yair Reem and his €300M venture capital firm, Extantia Capital, are not just imagining it—they're building it.
Tune in to discover how you can be part of this green gold rush!
🎙️ What's in the Episode:
1️⃣ The Urgency of Climate Change: Yair discusses why climate change is not just an environmental issue but a ticking time bomb that affects every sector of the economy.
2️⃣ The Role of Venture Capital: Learn how Extantia Capital is more than just a fund—it's a €300M platform that unites mission-driven entrepreneurs, scientists, and business leaders to advance the transition to a greener future.
3️⃣ The Multi-Trillion Dollar Opportunity: Yair shares insights into how the fight against climate change creates unprecedented business opportunities, potentially even 100x bigger than the internet revolution.
👨💼 About Yair Reem:
Yair Reem is more than an investor; he's a builder. From childhood Legos to Electrical Engineering and co-founding Extantia Capital, his path is fueled by a drive to make impact. With experience on both sides of investment, he knows what makes a firm succeed. His motto, "Do well by doing good," shows his belief that profit and impact can coexist.
💡 LINKS TO MORE CONTENT
Host:
Speaker
📌 Quotes:
(21:10) "The technologies we have today can only take us halfway to net zero emissions. There's a lot of technology that still needs to be developed and scaled to make it ready for the mass market."
(23:38) "To bridge the 50% gap in fighting climate change, we need to deploy capital to motivate scientists to develop new solutions and companies to scale those solutions."
(57:58) "When we look at the intersection of public and private sectors, we see that regulators are essential for both basic research and for making certain industries profitable where they currently aren't. But the key question remains: How do we ensure that these profits are reinvested to drive down costs and improve processes, rather than being siphoned off for other uses?"
(1:07:08) "The worst time to raise money is when you need it; the best time is when you don't."
(1:36:32) "We don't just take a good team and build a good product with them; we take a good team with a good product and help make that an excellent business."
(2:01:12) "My wish is that we will see much more peace in the future, thanks to ubiquitous and cheap energy."
⏰ Timestamps:
(03:30) Yair Reem's Journey: Electrical Engineering to Climate Tech
(09:33) Urgency of Climate Change
(21:10) Tech Gap: Net Zero Emissions by 2050
(22:06) Tech Innovation in Climate Change
(23:38) Bridging the 50% Gap
(30:36) Sustainability, Growth, Social Justice
(40:38) Short-Term Sacrifice for Long-Term Gain
(42:31) Role of Regulation in Climate Solutions
(48:47) Financial Returns in Climate Investments
(59:01) Airline Profits: Bankruptcy to Flourishing
(1:03:34) The Tim Cook Effect
(1:13:02) VC Ecosystems: Secret Sauce
(1:19:57) Art of Syndication in High-Stakes
(1:28:35) Retrofitting the Future
(1:39:40) Uninvestable Cap Tables
(1:40:56) Negotiating Equity with Universities
(1:47:44) Double-Edged Sword of Secondary Investments
(2:01:05) Future of Energy: Ubiquitous, Free Access
Send us Fan Mail
Support the show
Join the Podcast Newsletter: Link
Your Next Move: Link
"Are you tired of the long, winding road of drug discovery, full of dead-ends and costly detours? Do you wish there was a more efficient way to navigate the complex landscape of pharmaceutical R&D?
In this episode, we bring you the solution that promises to be the 'Google Maps' for drug discovery. Samantha Dale Strasser, PhD, CSO and co-founder of Pepper Bio, shares her revolutionary approach to drug discovery that's already making waves in the healthcare industry.
👉 Don't miss out on this game-changing conversation. Click below to watch the full episode or listen to the entire podcast.
🎉 Special thanks to our sponsors for making this episode possible.
Join my newsletter
Christian Soschner
Samantha Dale Strasser
Send us Fan Mail
Support the show
Join the Podcast Newsletter: Link
Your Next Move: Link
In this special episode, we bring you exclusive insights from Warren Buffett and Charlie Munger, straight from the Berkshire Hathaway 2023 Shareholder Meeting. They tackle the age-old investor's dilemma:
How to balance short-term profits with long-term sustainability. Whether you're a retail investor or running a multi-billion dollar fund, this episode is packed with wisdom you won't want to miss.
🎧 Don't forget to leave us a review and share this episode with your network!
🎧 Subscribe for more exclusive content from industry leaders.
🎧 Special thanks to our sponsors. Check out the companies that make this podcast possible!
Send us Fan Mail
Support the show
Join the Podcast Newsletter: Link
Your Next Move: Link
Is revolutionizing patient care through biotechnology an ambitious dream, or is it the future of medicine? Dr. Daniel Vitt, a leading figure in the biotech world, challenges the status quo and brings a fresh perspective to these questions.
Dr. Daniel Vitt is the CEO of Immunic Therapeutics, a company at the forefront of developing groundbreaking treatments for chronic inflammatory and autoimmune diseases. With a background in molecular biology and a passion for innovation, he is steering Immunic towards a future where patients have more effective and safer treatment options.
In this episode, we delve into:
• The visionary approach of Immunic Therapeutics in treating multiple sclerosis and leaky gut.
• The challenges and triumphs of bridging European and American biotech markets.
• The role of serendipity in scientific discovery and innovation.
• The future of Immunic: clinical trials, stock prices, and global expansion.
• Daniel’s three key lessons for anyone daring to start their own company in the biotech industry.
• Don't miss out on this insightful conversation. Subscribe to our channel and join us in exploring the future of biotech with Dr. Daniel Vitt.
💡 LINKS TO MORE CONTENT
Youtube
Christian Soschner:
Today’s speaker is Dr. Daniel Vitt:
📖 Memorable Quotes:
(00:02:23) "Every morning, when I go to work, I enjoy being part of an industry that improves patients' lives."
(00:05:26) "Understanding the key and lock principle in biology is our path to curing diseases."
(00:24:49) "Serendipity means you're searching for a needle in a haystack, but you find something unexpected and even more valuable."
(01:13:23) "If you are early and have a big vision, you can succeed easily."
(01:32:35) "Expect the unexpected and be prepared. Adaptability is key in our rapidly changing industry."
⏰ Timestamps:
(00:01:15) Unveiling the Future of Patient Care
(00:05:26) Decoding the Key-Lock Principle in Biology
(00:11:16) The Dynamic Dance of New Technologies in Healthcare
(00:16:54) Misconceptions: Multiple Sclerosis vs. Parkinson's
(00:17:41) Exploring the Link: MS, Parkinson's, and Neurodegeneration
(00:24:15) The Power of Serendipity in Scientific Discovery
(00:35:07) Addressing Celiac Disease: A New Approach
(00:39:10) The Challenges of Multicenter Multinational Studies
(00:48:49) A Potential Game-Changer: Restoring the Gut
(00:50:38) Western Lifestyle's Impact on Gut Health
(00:52:18) The Balance of Lifestyle and Disease
(01:02:12) The True Cost of Drug Development
(01:08:31) Unveiling a Multi-Billion Opportunity: The Market Potential
(01:12:40) The Bavarian Biotech Boom: A Tale of Visionary Politics
(01:22:31) Crossing the Atlantic: European Biotech’s Path to U.S. Success
(01:23:51) Navigating the Global Biotech Landscape: Daniel Vitt's Perspective
(01:26:41) The Next Leap: Interim Analysis of a Pivotal Phase Two Study
(01:32:35) Adaptability in Biotech: Learning from Biontech's Success Story
Send us Fan Mail
Support the show
Join the Podcast Newsletter: Link
Your Next Move: Link
Ever wondered how AI is revolutionizing drug discovery?
Dive into this insightful conversation with Marco Schmidt, the brilliant mind behind Biotx.ai.
As the CSO, Marco has been at the forefront of leveraging AI and genetics to predict drug success. In this clip, he shares his journey from data interpretation to predictive statistics, the inception of Biotx.ai, and the transformative impact of artificial intelligence on drug development.
Discover the future of medicine and the role of AI in shaping it.
If you find this intriguing, don't forget to like, comment, subscribe, and share.
Let's drive the conversation forward!
Full episode
Join my newsletter
Check out the sponsors to support the show
Full Episode
Christian Soschner
Marco Schmidt
Send us Fan Mail
Support the show
Join the Podcast Newsletter: Link
Your Next Move: Link
Ever feel like your emotions are driving your investment decisions? You're not alone. It's a wild ride in the investment world, and it's all too easy to let our emotions take the wheel. But here's a secret from two of the greatest investors of our time, Warren Buffett and Charlie Munger.
In this clip from the 2023 Berkshire Hathaway Shareholder Meeting, they spill the beans on how they keep their emotions in check. They've made their fair share of bad investment decisions, but they've never let their emotions dictate their choices.
This is a game-changer, folks. The market is a roller coaster, and if we let fear and greed take over, we're in for a bumpy ride. But Buffett and Munger remind us to stay cool, calm, and collected.
Investing isn't about making a quick buck or panicking when things go south. It's about making smart choices based on solid research and sticking to your guns, even when the market is doing somersaults.
So the next time you feel your heart racing or your palms sweating over your investments, take a deep breath and channel your inner Buffett. Keep those emotions in check, stay disciplined, and keep your eyes on the prize.
Check out the clip to hear it straight from Buffett and Munger. And don't forget to share it with your fellow investors. The more we learn, the better we can navigate the wild world of investing.
Youtube
Send us Fan Mail
Support the show
Join the Podcast Newsletter: Link
Your Next Move: Link
Climate change is here, and it's urgent.
In this clip, Dr. Kimberley R. Miner, a Climate Scientist at NASA, unveils her top three actions to combat climate change.
From halting carbon emissions to preserving biodiversity, Kimberley's insights are a must-listen for anyone concerned about our planet's future.
Tune in to discover what we can do today to safeguard tomorrow.
Don't forget to subscribe for more insights! This is a conversation you won't want to miss.
Join my newsletter
Check out the sponsors to support the show
Full Episode
Christian Soschner
Kimberley Miner
Send us Fan Mail
Support the show
Join the Podcast Newsletter: Link
Your Next Move: Link
"Believe in the team, invest the money." This is Philipp Baaske, founder and CEO of NanoTemper Technologies.
His company, a global biotech powerhouse, is on a mission to create a world where every disease is treatable.
Philipp's journey from a small Bavarian village to leading a global team of 240 is inspiring. His company now generates over 35 million in annual revenue.
His secret? Start small, dream big, and invest profits back into the business.
In this clip, Philipp shares his insights. He talks about the importance of angel investors in startups.
They're not just financial backers. They're partners. They're believers in the team and the vision.
His story echoes the audacity of tech giants. Like Bill Gates selling an operating system before it was fully developed. Like Steve Jobs' relentless focus on customer experience at Apple.
Join us for this enlightening conversation. Philipp offers a rare glimpse into the world of startups. He talks about the dynamics between startups and their angel investors. He emphasizes the importance of trust.
Click play. Dive into the world of startups and angel investing.
Don't forget to subscribe for more insights! This is a conversation you won't want to miss.
Join my newsletter
Check out the sponsors to support the show
Full Episode
Christian Soschner
Philipp Baaske
Send us Fan Mail
Support the show
Join the Podcast Newsletter: Link
Your Next Move: Link
Is investing in climate tech just a trend, or is it the future of venture capital? Doerte Hirschberg, a leading figure in the VC world, challenges the status quo and brings a fresh perspective to these questions.
Doerte Hirschberg is the co-founder and managing partner of Climentum Capital, a venture capital firm that focuses on climate tech investments. With a background in traditional investments, she has transitioned into the climate tech space, bringing with her a wealth of knowledge and a unique perspective on the intersection of business viability and environmental sustainability.
In this episode, we delve into:
💡 LINKS TO MORE CONTENT
Youtube
Christian Soschner
Today’s speaker is Doerte Hirschberg
📖 Memorable Quotes:
(04:49) "Installing solar and investing in energy-saving technologies make sense from a business case point of view."
(15:04) "Climate change and CO2 emissions are measurable impact topics, making our fund's impact target as credible as our financial ones."
(35:04) "In the VC investment field, you mostly have male teams or one woman, especially in the industrial sector."
(39:17) "The traditional venture capital game is about the winner. Women, making up 50% of consumers, can see many trends and insights more clearly."
(01:06:37) "My aspiration is a transition towards a more sustainable industry and society, reducing extreme poverty and maintaining Earth as a livable place."
⏰ Timestamps:
(00:01:00) Initiating Discussion on Climate Change Investments
(00:02:42) Transitioning from Traditional Investments to Climate Tech
(00:05:33) The Intersection of Climate Tech and Business Viability
(00:12:02) Exploring the Power of University Innovations
(00:14:10) The Art and Science of CO2 Investing
(00:20:16) The Intersection of Technical Expertise and Global Reach
(00:26:02) Pragmatism in Green Transition
(00:30:02) The Role of Capitalism in Green Innovation
(00:34:02) Embracing Diversity in the Green Sector
(00:38:47) Risk Aversion: Women as Better Investors?
(00:40:07) Closing the Gender Gap in VC Investment
(00:46:06) The Role of VCs in Startup Success and Growth
(00:51:14) Unveiling the Unique Selling Proposition in Venture Capital
(00:52:13) The Journey of a New Fund: From First Closing to Future Aspirations
(01:01:32) The Role of Regulations and Capital in Shaping Europe's Climate Tech Future
(01:05:46) Investing in Venture Funds: The Right Time and Momentum
(01:06:37) Vision for a Sustainable Future: From Dreams to Reality
(01:09:08) Investing in Innovation: The Case of Vegan Cheese
(01:20:58) Harnessing Power and Energy from Diverse Engagements
(01:22:46) Efficiency in Balancing Work and Family Life
(01:25:24) The Role and Impact of White Papers in Investment
Send us Fan Mail
Support the show
Join the Podcast Newsletter: Link
Your Next Move: Link